Saturday 17 October 2026
Export GRDX’s income statement to Excel — free account
GridAI Technologies Corp.
GRDX Healthcare Biotechnology
GridAI Technologies Corp.’s revenue for fiscal 2025 (year ended December 2025) was $36,300.00. In the quarter to June 2026, EPS fell 219.0%, free cash flow fell 2,641.0% and total debt fell 64.0%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years.
4.22
0.24
−5.38%
Follow GRDX
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
— | — | 0.00 | 0.00 |
P/S ratio |
— | — | 0.00 | 0.00 | |
P/FCF ratio |
— | — | 0.00 | 0.00 | |
P/Operating CF |
— | — | (5.03) | (20.01) | |
P/B ratio |
— | — | 0.38 | 2.02 | |
Price to Tangible BV |
— | — | 0.00 | 0.00 | |
EV/Sales |
— | — | 0.00 | 0.00 | |
EV/EBITDA |
— | — | 0.00 | 0.00 | |
EV/Operating CF |
— | — | (2.29) | (4.36) | |
EV/FCF |
— | — | (2.30) | (4.37) | |
Quick Ratio |
0.08 | 0.15 | 0.14 | 0.13 | |
Current Ratio |
2.62 | 0.17 | 0.16 | 0.16 | |
Net Debt/EBITDA |
1.94 | 0.13 | 0.04 | 0.53 | |
Debt/Assets |
0.52% | 0.55% | 0.55% | 0.68% | |
Debt/Equity |
0.01 | 0.01 | 0.01 | 0.01 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.69 | 1.30 | 0.49 | 0.12 | |
Capex/Depreciation |
— | 0.00 | 0.00 | 0.00 | |
Interest Coverage |
— | (9.91) | (6.92) | — | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 1,652.88% | 9.78% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 6,202.62% | 3,482.77% | |
Intangible Assets out of Total Assets |
0.33 | 0.90 | 0.90 | 0.88 | |
Share Based Compensation of Revenue |
— | 0.00% | 1,943.19% | 678.11% | |
Graham Net Nets |
— | — | (1.99) | (0.53) | |
Graham Number |
— | — | 0.00 | 0.00 | |
Earnings Yield |
— | — | (225.43%) | (126.52%) | |
Free Cash Flow Yield |
— | — | (73.96%) | (26.91%) | |
Revenue per Share |
0.00 | 0.00 | 0.01 | 0.01 | |
Operating CF per Share |
(0.52) | (2.46) | (0.40) | (0.23) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(0.52) | (2.46) | (0.40) | (0.23) | |
Cash per Share |
1.52 | 0.56 | 0.09 | 0.21 | |
Shareholders Equity per Share |
54.19 | 17.83 | 6.18 | 2.92 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
54.19 | 17.83 | 6.18 | 2.92 | |
Free Cash Flow |
(0.86) | (3.97) | (1.79) | (1.50) | |
Working Capital |
54.18 | (12.56) | (13.65) | (11.85) | |
Net Current Asset Value |
41.89 | (17.12) | (17.89) | (15.97) | |
EV/EBIT |
— | — | 0.00 | 0.00 | |
Capex to Sales |
— | — | 0.00 | 0.00 | |
Price to Operating Income |
— | — | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
0.05 | 0.77 | 0.99 | 0.24 | |
Average Payables |
3.59 | 3.17 | 3.46 | 2.80 | |
Average Assets |
110.60 | 66.98 | 66.58 | 61.05 | |
Average Common Equity |
18.13 | 10.53 | 9.19 | 4.29 |
Columns are period end dates · fundamentals updated 2 Oct 2026